Pharmaceutical Localization Is Drawing Fresh Capital

Several new projects aimed at localising the production of domestic medicines have moved forward this year as part of the broader non-resource investment push, alongside smaller allocations tied to healthcare within sovereign investment vehicles. This remains an early-stage opportunity worth tracking as specific manufacturing partners and equipment suppliers are identified.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.